The COVID-19 pandemic has put the inequality in health outcomes in the United States center stage. What can the healthcare industry do to begin to address disparities in health outcomes? Precision’s Jason Shafrin and Meena Venkatachalam discuss how improving the representativeness of clinical trials and updating our value assessment frameworks can help improve health outcomes for the most disadvantaged in our society.